Dexmedetomidine administration in a patient with status epilepticus under color density spectral array monitoring.
Anesthesia
Color density spectral array
Dexmedetomidine
Processed electroencephalogram
Status epilepticus
Journal
JA clinical reports
ISSN: 2363-9024
Titre abrégé: JA Clin Rep
Pays: Germany
ID NLM: 101682121
Informations de publication
Date de publication:
27 Feb 2019
27 Feb 2019
Historique:
received:
17
01
2019
accepted:
20
02
2019
entrez:
7
2
2020
pubmed:
7
2
2020
medline:
7
2
2020
Statut:
epublish
Résumé
Status epilepticus requires immediate treatment because treatment delay can cause permanent neurologic complications. Dexmedetomidine may be an option for the treatment of status epilepticus although its effect remains unclear with conflicting reports. A 64-year-old woman with epilepsy with complex partial seizures underwent total knee arthroplasty. After emergence from general anesthesia, she developed status epilepticus and was transferred to the intensive care unit. Following initial treatment using benzodiazepines, phenytoin, and levetiracetam, dexmedetomidine (0.37 μg/kg loading in 10 min followed by 0.6 μg/kg/h) was administered and seizures terminated in 20 min. Color density spectral array using Root® with SedLine® (Masimo, Irvine, CA, USA) showed an increase in power in high frequency band of the electroencephalogram during the seizure attacks. We described a case of status epilepticus which was treated with dexmedetomidine and monitored using color density spectral array.
Sections du résumé
BACKGROUND
BACKGROUND
Status epilepticus requires immediate treatment because treatment delay can cause permanent neurologic complications. Dexmedetomidine may be an option for the treatment of status epilepticus although its effect remains unclear with conflicting reports.
CASE PRESENTATION
METHODS
A 64-year-old woman with epilepsy with complex partial seizures underwent total knee arthroplasty. After emergence from general anesthesia, she developed status epilepticus and was transferred to the intensive care unit. Following initial treatment using benzodiazepines, phenytoin, and levetiracetam, dexmedetomidine (0.37 μg/kg loading in 10 min followed by 0.6 μg/kg/h) was administered and seizures terminated in 20 min. Color density spectral array using Root® with SedLine® (Masimo, Irvine, CA, USA) showed an increase in power in high frequency band of the electroencephalogram during the seizure attacks.
CONCLUSION
CONCLUSIONS
We described a case of status epilepticus which was treated with dexmedetomidine and monitored using color density spectral array.
Identifiants
pubmed: 32026959
doi: 10.1186/s40981-019-0234-1
pii: 10.1186/s40981-019-0234-1
pmc: PMC6967278
doi:
Types de publication
Journal Article
Langues
eng
Pagination
12Commentaires et corrections
Type : ErratumIn
Références
J Neurosurg Anesthesiol. 2007 Jul;19(3):195-9
pubmed: 17592352
Epilepsia. 2008 Jul;49(7):1277-85
pubmed: 18638280
Anesth Analg. 2005 Mar;100(3):687-96, table of contents
pubmed: 15728053
Epilepsia. 2015 Oct;56(10):1515-23
pubmed: 26336950
Br J Anaesth. 1999 Jun;82(6):935-7
pubmed: 10562794
Anesthesiology. 1994 Dec;81(6):1422-8
pubmed: 7992911
Epilepsia. 1999 Jun;40(6):759-62
pubmed: 10368075
Brain Dev. 2013 Apr;35(4):360-2
pubmed: 22727734
Korean J Anesthesiol. 2013 Jul;65(1):93-4
pubmed: 23904950
Anesth Analg. 2007 Nov;105(5):1272-7, table of contents
pubmed: 17959954
J Clin Neurophysiol. 2013 Aug;30(4):371-5
pubmed: 23912575
Anesth Analg. 2010 Sep;111(3):729-35
pubmed: 20547823
Anesthesiology. 2002 Sep;97(3):693-700
pubmed: 12218537
Br J Anaesth. 2017 Aug 1;119(2):200-210
pubmed: 28854538